Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in J Neurochem

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    August 2017
  1. MYTHRI RB, Raghunath NR, Narwade SC, Pandareesh MD, et al
    Manganese and 1-methyl-4-phenylpyridinium (MPP+ ) induced neurotoxicity indicate differences in morphological, electrophysiological and genome-wide alterations: Implications for idiopathic Parkinson's disease.
    J Neurochem. 2017 Aug 12. doi: 10.1111/jnc.14147.
    PubMed     Text format     Abstract available


  2. DAS BANERJEE T, Dagda RY, Dagda M, Chu CT, et al
    PINK1 regulates mitochondrial trafficking in dendrites of cortical neurons through mitochondrial PKA.
    J Neurochem. 2017;142:545-559.
    PubMed     Text format     Abstract available


    June 2017
  3. HAVELUND JF, Andersen AD, Binzer M, Blaabjerg M, et al
    Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.
    J Neurochem. 2017 Jun 19. doi: 10.1111/jnc.14104.
    PubMed     Text format     Abstract available


    May 2017
  4. LEIKAS JV, Kohtala S, Theilmann W, Jalkanen AJ, et al
    Brief isoflurane anesthesia regulates striatal AKT-GSK3beta signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.
    J Neurochem. 2017 May 10. doi: 10.1111/jnc.14066.
    PubMed     Text format     Abstract available


    April 2017
  5. AY M, Luo J, Langley M, Jin H, et al
    Molecular Mechanisms Underlying Protective Effects of Quercetin Against Mitochondrial Dysfunction and Progressive Dopaminergic Neurodegeneration in Cell Culture and MitoPark Transgenic Mouse Models of Parkinson's Disease.
    J Neurochem. 2017 Apr 4. doi: 10.1111/jnc.14033.
    PubMed     Text format     Abstract available


  6. KANNINEN KM, White AR
    Type-I interferons in Parkinson's disease: innate inflammatory response drives fate of neurons in model of degenerative brain disorder: An editorial comment on 'Type-I interferons mediate the neuroinflammatory response and neurotoxicity induced by rot
    J Neurochem. 2017;141:9-11.
    PubMed     Text format     Abstract available


    March 2017
  7. CRUCES-SANDE A, Mendez-Alvarez E, Soto-Otero R
    Copper increases the ability of 6-hydroxydopamine to generate oxidative stress and the ability of ascorbate and glutathione to potentiate this effect: potential implications in Parkinson's disease.
    J Neurochem. 2017 Mar 14. doi: 10.1111/jnc.14019.
    PubMed     Text format     Abstract available


  8. BECKER G, Mohamed Ali B, Michel A, Hustadt F, et al
    Comparative assessment of 6-[18 F]fluoro-L-m-tyrosine and 6-[18 F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson's disease rat model.
    J Neurochem. 2017 Mar 10. doi: 10.1111/jnc.14016.
    PubMed     Text format     Abstract available


    February 2017
  9. ANDERSEN AD, Blaabjerg M, Binzer M, Kamal A, et al
    Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: Effect of L-DOPA treatment and changes in levodopa-induced dyskinesia.
    J Neurochem. 2017 Feb 28. doi: 10.1111/jnc.13997.
    PubMed     Text format     Abstract available


    January 2017
  10. FALKENBURGER B
    ExPPNing how acetylcholine improves gait in Parkinson's disease: An Editorial Highlight for 'Deletion of the Vesicular Acetylcholine Transporter from Pedunculopontine/laterodorsal tegmental neurons modifies gait'.
    J Neurochem. 2017 Jan 6. doi: 10.1111/jnc.13899.
    PubMed     Text format     Abstract available


    September 2016
  11. KOMNIG D, Schulz JB, Reich A, Falkenburger BH, et al
    Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson Disease.
    J Neurochem. 2016 Sep 17. doi: 10.1111/jnc.13847.
    PubMed     Text format     Abstract available


    August 2016
  12. SCHULZ JB, Hausmann L, Hardy J
    199 years of Parkinson disease - what have we learned and what is the path to the future?
    J Neurochem. 2016 Aug 31. doi: 10.1111/jnc.13733.
    PubMed     Text format     Abstract available


  13. OERTEL W, Schulz JB
    Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
    J Neurochem. 2016 Aug 30. doi: 10.1111/jnc.13750.
    PubMed     Text format     Abstract available


  14. BOSE A, Beal MF
    Mitochondrial dysfunction in Parkinson's disease.
    J Neurochem. 2016 Aug 21. doi: 10.1111/jnc.13731.
    PubMed     Text format     Abstract available


    July 2016
  15. SVEINBJORNSDOTTIR S
    The clinical symptoms of Parkinson's disease.
    J Neurochem. 2016 Jul 11. doi: 10.1111/jnc.13691.
    PubMed     Text format     Abstract available


  16. YANG TC, Wu PC, Chung IF, Jiang JH, et al
    Cell Death Caused by the Synergistic Effects of Zinc and Dopamine is Mediated by a Stress Sensor Gene Gadd45b - Implication in the Pathogenesis of Parkinson's Disease.
    J Neurochem. 2016 Jul 6. doi: 10.1111/jnc.13728.
    PubMed     Text format     Abstract available


  17. TOULORGE D, Schapira AH, Hajj R
    Molecular changes in the postmortem parkinsonian brain.
    J Neurochem. 2016 Jul 5. doi: 10.1111/jnc.13696.
    PubMed     Text format     Abstract available


    June 2016
  18. QI X, Davis B, Chiang YH, Filichia E, et al
    Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
    J Neurochem. 2016 Jun 18. doi: 10.1111/jnc.13706.
    PubMed     Text format     Abstract available


    May 2016
  19. VIANA SD, Valero J, Rodrigues-Santos P, Couceiro P, et al
    Regulation of striatal astrocytic RAGE variants in an early stage of experimental Parkinson's disease.
    J Neurochem. 2016 May 25. doi: 10.1111/jnc.13682.
    PubMed     Text format     Abstract available


  20. VOGT WEISENHORN DM, Giesert F, Wurst W
    Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.
    J Neurochem. 2016 May 21. doi: 10.1111/jnc.13670.
    PubMed     Text format     Abstract available


    April 2016
  21. WULLNER U, Kaut O, deBoni L, Piston D, et al
    DNA methylation in Parkinson's disease.
    J Neurochem. 2016 Apr 27. doi: 10.1111/jnc.13646.
    PubMed     Text format     Abstract available


  22. FALKENBURGER BH, Saridaki T, Dinter E
    Cellular models for Parkinson's disease.
    J Neurochem. 2016 Apr 18. doi: 10.1111/jnc.13618.
    PubMed     Text format     Abstract available


  23. HERNANDEZ DG, Reed X, Singleton AB
    Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.
    J Neurochem. 2016 Apr 18. doi: 10.1111/jnc.13593.
    PubMed     Text format     Abstract available


    March 2016
  24. VOLPICELLI-DALEY LA, Kirik D, Stoyka LE, Standaert DG, et al
    How can rAAV-alpha-synuclein and the fibril alpha-synuclein models advance our understanding of Parkinson disease?
    J Neurochem. 2016 Mar 28. doi: 10.1111/jnc.13627.
    PubMed     Text format     Abstract available


  25. TONOUCHI A, Nagai J, Togashi K, Goshima Y, et al
    Loss of CRMP4 suppresses dopaminergic neuron death in an MPTP-induced mouse model of Parkinson's disease.
    J Neurochem. 2016 Mar 16. doi: 10.1111/jnc.13617.
    PubMed     Text format     Abstract available


  26. GUERRA DE SOUZA AC, Prediger RD, Cimarosti H
    Mitochondrial dysfunction and SUMOylation targets in Parkinson's disease.
    J Neurochem. 2016 Mar 2. doi: 10.1111/jnc.13599.
    PubMed     Text format     Abstract available


  27. CHASSAIN C, Melon C, Salin P, Vitale F, et al
    Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
    J Neurochem. 2016;136:1004-16.
    PubMed     Text format     Abstract available


    February 2016
  28. MARTIN I, Kim JW, Dawson VL, Dawson TM, et al
    LRRK2 pathobiology in Parkinson's disease - virtual inclusion.
    J Neurochem. 2016 Feb 22. doi: 10.1111/jnc.13549.
    PubMed     Text format     Abstract available


  29. BAYLISS JA, Lemus M, Santos VV, Deo M, et al
    Acylated but not des-acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's Disease.
    J Neurochem. 2016 Feb 12. doi: 10.1111/jnc.13576.
    PubMed     Text format     Abstract available


  30. BLANZ J, Saftig P
    Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    J Neurochem. 2016 Feb 10. doi: 10.1111/jnc.13517.
    PubMed     Text format     Abstract available


  31. MIGDALSKA-RICHARDS A, Schapira AH
    The relationship between glucocerebrosidase mutations and Parkinson disease.
    J Neurochem. 2016 Feb 10. doi: 10.1111/jnc.13385.
    PubMed     Text format     Abstract available


  32. DUDA J, Potschke C, Liss B
    Converging roles of ion channels, calcium, metabolic stress, and activity-pattern of substantia nigra dopaminergic neurons in health and Parkinson's disease.
    J Neurochem. 2016 Feb 10. doi: 10.1111/jnc.13572.
    PubMed     Text format     Abstract available


  33. BENSKEY MJ, Perez RG, Manfredsson FP
    The contribution of alpha synuclein to neuronal survival and function Implications for Parkinson's Disease.
    J Neurochem. 2016 Feb 6. doi: 10.1111/jnc.13570.
    PubMed     Text format     Abstract available


  34. WILLIAMS S
    Kurtosis imaging reveals microstructural changes of late-stage alpha-synuclein accumulation in a mouse model of Parkinson's disease.
    J Neurochem. 2016 Feb 1. doi: 10.1111/jnc.13522.
    PubMed     Text format     Abstract available


    January 2016
  35. VALERA E, Masliah E
    Therapeutic approaches in Parkinson's disease and related disorders.
    J Neurochem. 2016 Jan 9. doi: 10.1111/jnc.13529.
    PubMed     Text format     Abstract available


  36. BRUDEK T, Winge K, Rasmussen NB, Bahl JM, et al
    Altered alpha-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    J Neurochem. 2016;136:172-85.
    PubMed     Text format     Abstract available


    December 2015
  37. KHAIRNAR A, Ruda-Kucerova J, Drazanova E, Szabo N, et al
    Late-stage alpha-synuclein accumulation in TNWT-61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging.
    J Neurochem. 2015 Dec 19. doi: 10.1111/jnc.13500.
    PubMed     Text format     Abstract available


    November 2015
  38. BELAIDI AA, Bush AI
    Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    J Neurochem. 2015 Nov 6. doi: 10.1111/jnc.13425.
    PubMed     Text format     Abstract available


    October 2015
  39. MUNOZ-MANCHADO AB, Villadiego J, Romo-Madero S, Suarez-Luna N, et al
    Chronic and progressive Parkinson's disease MPTP model in adult and aged mice.
    J Neurochem. 2015 Oct 26. doi: 10.1111/jnc.13409.
    PubMed     Text format     Abstract available


  40. MIYAZAKI I, Murakami S, Torigoe N, Kitamura Y, et al
    Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian model mice.
    J Neurochem. 2015 Oct 20. doi: 10.1111/jnc.13405.
    PubMed     Text format     Abstract available


  41. MOLLENHAUER B, Parnetti L, Rektorova I, Kramberger MG, et al
    Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
    J Neurochem. 2015 Oct 10. doi: 10.1111/jnc.13390.
    PubMed     Text format     Abstract available


    September 2015
  42. BLUM R, Lesch KP
    Parkinson's disease, anxious depression and serotonin - zooming in on hippocampal neurogenesis.
    J Neurochem. 2015 Sep 17. doi: 10.1111/jnc.13278.
    PubMed     Text format     Abstract available


    August 2015
  43. CHEN P, Chakraborty S, Mukhopadhyay S, Lee E, et al
    Manganese homeostasis in the nervous system.
    J Neurochem. 2015;134:601-10.
    PubMed     Text format     Abstract available


    July 2015
  44. AY M, Jin H, Harischandra DS, Asaithambi A, et al
    Molecular Cloning, Epigenetic Regulation and Functional Characterization of Prkd1 Gene Promoter in Dopaminergic Cell Culture Models of Parkinson's Disease.
    J Neurochem. 2015 Jul 31. doi: 10.1111/jnc.13261.
    PubMed     Text format     Abstract available


  45. BEILINA A, Cookson MR
    Genes associated with Parkinson's disease: regulation of autophagy and beyond.
    J Neurochem. 2015 Jul 30. doi: 10.1111/jnc.13266.
    PubMed     Text format     Abstract available


  46. DEUSSER J, Schmidt S, Ettle B, Plotz S, et al
    Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
    J Neurochem. 2015 Jul 23. doi: 10.1111/jnc.13253.
    PubMed     Text format     Abstract available


  47. XU Y, Deng Y, Qing H
    The phosphorylation of alpha-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease.
    J Neurochem. 2015 Jul 2. doi: 10.1111/jnc.13234.
    PubMed     Text format     Abstract available


    May 2015
  48. FUZZATI-ARMENTERO MT, Cerri S, Levandis G, Ambrosi G, et al
    Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease.
    J Neurochem. 2015 May 12. doi: 10.1111/jnc.13162.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: